Hunter C Smith Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

RYTM Quotes by TradingView

Hunter C Smith is Chief Financial Officer of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 97,939 shares of RYTM, which is worth approximately $4.81 Million. The most recent transaction as insider was on Feb 15, 2022, when has been sold 833 shares (Common Stock) at a price of $6.1 per share, resulting in proceeds of $5,081. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97.9K
0% 3M change
59.49% 12M change
Total Value Held $4.81 Million

Hunter C Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2022
SELL
Open market or private sale
$5,081 $6.1 p/Share
833 Reduced 2.03%
40,161 Common Stock
Feb 11 2022
BUY
Exercise of conversion of derivative security
-
2,344 Added 5.41%
40,994 Common Stock
Apr 21 2021
BUY
Exercise of conversion of derivative security
$34,400 $6.88 p/Share
5,000 Added 11.45%
38,650 Common Stock
Jan 19 2021
BUY
Exercise of conversion of derivative security
$27,520 $6.88 p/Share
4,000 Added 10.62%
33,650 Common Stock

Also insider at

AGLE
Aeglea BioTherapeutics, Inc. Healthcare
Director
HCS

Hunter C Smith

Chief Financial Officer
Boston, MA

Track Institutional and Insider Activities on RYTM

Follow RHYTHM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RYTM